STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G] SI-BONE, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Champlain Investment Partners, LLC reported beneficial ownership of 2,140,074 shares of SI-BONE, Inc. common stock, representing 5.0% of the outstanding class. The filing states Champlain is organized in Vermont and acts as an investment adviser.

The report breaks down voting and dispositive power: 1,368,619 shares are listed as sole voting power and 2,140,074 shares as sole dispositive power. The filer certifies the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Positive

  • Beneficial ownership disclosed: Champlain reports 2,140,074 shares (5.0%), providing investor transparency
  • Clear authority breakdown: Filing specifies 1,368,619 sole voting power and 2,140,074 sole dispositive power
  • Certification of passive intent: States holdings were acquired and are held in the ordinary course and not to influence control

Negative

  • None.

Insights

TL;DR: Champlain discloses a passive 5.0% stake in SI-BONE with full dispositive control and significant sole voting power.

The filing is a routine Schedule 13G disclosure showing a 2,140,074-share position equal to 5.0% of the class. As an investment adviser reporting under the passive 13G regime, the filing signals a material but non-controlling economic interest. The split between 1,368,619 sole voting shares and 2,140,074 sole dispositive shares clarifies governance versus disposal authority. This is informational for holders and market participants but does not indicate an intent to change control.

TL;DR: Disclosure improves transparency; ownership size merits monitoring but does not alone imply activist intent.

The statement includes the required certification that the securities are held in the ordinary course and not to influence control, consistent with Schedule 13G treatment. Ownership at exactly 5.0% is a regulatory threshold that triggers visibility; governance implications depend on future activity, votes, or additional acquisitions. For now, the filing documents voting and dispositive authority without alleging coordination with other holders or group formation.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Champlain Investment Partners, LLC
Signature:Matthew Garcia
Name/Title:Chief Compliance Officer
Date:08/12/2025

FAQ

How many SI-BONE (SIBN) shares does Champlain Investment Partners report owning?

Champlain reports beneficial ownership of 2,140,074 shares of SI-BONE common stock.

What percentage of SI-BONE does Champlain own according to the Schedule 13G?

The filing states Champlain owns 5.0% of the outstanding class of SI-BONE common stock.

How much voting power does Champlain report for SIBN shares?

Champlain reports 1,368,619 shares as sole voting power and 0 shared voting power.

Does Champlain claim the shares are held to influence control of SI-BONE?

No. The filing includes a certification that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control.

What authority does Champlain have over disposal of the SIBN shares?

The filing lists 2,140,074 shares as sole dispositive power and 0 shared dispositive power.
Si-Bone

NASDAQ:SIBN

SIBN Rankings

SIBN Latest News

SIBN Latest SEC Filings

SIBN Stock Data

845.70M
39.55M
2.98%
96.62%
5.01%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
SANTA CLARA